BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23723416)

  • 21. Different levels, but not different isoforms, of the Drosophila transcription factor DMEF2 affect distinct aspects of muscle differentiation.
    Gunthorpe D; Beatty KE; Taylor MV
    Dev Biol; 1999 Nov; 215(1):130-45. PubMed ID: 10525355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain.
    Zhu B; Ramachandran B; Gulick T
    J Biol Chem; 2005 Aug; 280(31):28749-60. PubMed ID: 15834131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of neuroprotective activity of myocyte-enhancer factor 2 by cAMP-protein kinase A signaling pathway in neuronal survival.
    Wang X; Tang X; Li M; Marshall J; Mao Z
    J Biol Chem; 2005 Apr; 280(17):16705-13. PubMed ID: 15735306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential regulation of the muscle-specific GLUT4 enhancer in regenerating and adult skeletal muscle.
    Moreno H; Serrano AL; Santalucía T; Gumá A; Cantó C; Brand NJ; Palacin M; Schiaffino S; Zorzano A
    J Biol Chem; 2003 Oct; 278(42):40557-64. PubMed ID: 12893821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MyoD is indispensable for muscle-specific alternative splicing in mouse mitochondrial ATP synthase gamma-subunit pre-mRNA.
    Ichida M; Endo H; Ikeda U; Matsuda C; Ueno E; Shimada K; Kagawa Y
    J Biol Chem; 1998 Apr; 273(14):8492-501. PubMed ID: 9525963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis.
    Karamboulas C; Dakubo GD; Liu J; De Repentigny Y; Yutzey K; Wallace VA; Kothary R; Skerjanc IS
    J Cell Sci; 2006 Oct; 119(Pt 20):4315-21. PubMed ID: 17003108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the MEF2 family of transcription factors by p38.
    Zhao M; New L; Kravchenko VV; Kato Y; Gram H; di Padova F; Olson EN; Ulevitch RJ; Han J
    Mol Cell Biol; 1999 Jan; 19(1):21-30. PubMed ID: 9858528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MEF2A and MEF2D isoforms are differentially regulated in muscle and adipose tissue during states of insulin deficiency.
    Mora S; Yang C; Ryder JW; Boeglin D; Pessin JE
    Endocrinology; 2001 May; 142(5):1999-2004. PubMed ID: 11316766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors.
    McDermott JC; Cardoso MC; Yu YT; Andres V; Leifer D; Krainc D; Lipton SA; Nadal-Ginard B
    Mol Cell Biol; 1993 Apr; 13(4):2564-77. PubMed ID: 8455629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of neuronal survival factor MEF2D by glycogen synthase kinase 3beta in neuronal apoptosis.
    Wang X; She H; Mao Z
    J Biol Chem; 2009 Nov; 284(47):32619-26. PubMed ID: 19801631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A molecular mechanism of temperature sensitivity for mutations affecting the Drosophila muscle regulator Myocyte enhancer factor-2.
    Lovato TL; Adams MM; Baker PW; Cripps RM
    Genetics; 2009 Sep; 183(1):107-17. PubMed ID: 19564485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2.
    Nojima M; Huang Y; Tyagi M; Kao HY; Fujinaga K
    J Mol Biol; 2008 Oct; 382(2):275-87. PubMed ID: 18662700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skeletal muscle specification by myogenin and Mef2D via the SWI/SNF ATPase Brg1.
    Ohkawa Y; Marfella CG; Imbalzano AN
    EMBO J; 2006 Feb; 25(3):490-501. PubMed ID: 16424906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential localization of HDAC4 orchestrates muscle differentiation.
    Miska EA; Langley E; Wolf D; Karlsson C; Pines J; Kouzarides T
    Nucleic Acids Res; 2001 Aug; 29(16):3439-47. PubMed ID: 11504882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders.
    Bachinski LL; Sirito M; Böhme M; Baggerly KA; Udd B; Krahe R
    Muscle Nerve; 2010 Dec; 42(6):856-63. PubMed ID: 21104860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C.
    Sartorelli V; Huang J; Hamamori Y; Kedes L
    Mol Cell Biol; 1997 Feb; 17(2):1010-26. PubMed ID: 9001254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helix-loop-helix transcription factors Myf-5 and MyoD.
    Winter B; Braun T; Arnold HH
    J Biol Chem; 1993 May; 268(13):9869-78. PubMed ID: 8387507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR.
    Creemers EE; Sutherland LB; Oh J; Barbosa AC; Olson EN
    Mol Cell; 2006 Jul; 23(1):83-96. PubMed ID: 16818234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of lysine methylation in myocyte enhancer factor 2 during skeletal muscle cell differentiation.
    Choi J; Jang H; Kim H; Lee JH; Kim ST; Cho EJ; Youn HD
    Nucleic Acids Res; 2014 Jan; 42(1):224-34. PubMed ID: 24078251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A myocyte enhancer factor 2D (MEF2D) kinase activated during neuronal apoptosis is a novel target inhibited by lithium.
    Linseman DA; Cornejo BJ; Le SS; Meintzer MK; Laessig TA; Bouchard RJ; Heidenreich KA
    J Neurochem; 2003 Jun; 85(6):1488-99. PubMed ID: 12787068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.